![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Biorez Receives FDA Clearance for Soft-Tissue Scaffold
Biorez Receives FDA Clearance for Soft-Tissue Scaffold
The FDA has granted Biorez 510(k) clearance for its BioBrace Implant, a soft-tissue scaffold designed for use in a range of surgical procedures.
The biocomposite scaffold reinforces soft tissue in weak areas and can be used with existing surgical techniques and instruments.
The implant features a highly porous collagen matrix and resorbable poly-L-lactide microfilaments that enable the scaffold to reinforce tendon and ligament repairs and encourage healing.
Upcoming Events
-
21Oct